We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Sontiges.
- Abstract
The generic and biosimilar manufacturer Sandoz is planning to build a new biologics production facility in Lendava, Slovenia. The investment of at least $400 million is one of the largest international investments by the private sector in Slovenia. Evonik has opened a new GMP facility in Hanau to produce lipids for pharmaceutical applications. BASF is investing in a new citral plant in China and in facilities for further processing of menthol and linalool in Ludwigshafen. Biontech and the Weizmann Institute have signed a memorandum of understanding for joint research to take place at Biontech's new mRNA Excellence Center in Israel. Euroapi is resuming prostaglandin production in Budapest after it was temporarily suspended due to deficiencies in GMP documentation. SIG plans to build its first aseptic carton packaging plant in India.
- Subjects
SLOVENIA; LETTERS of intent; ASEPTIC packaging; FOREIGN investments; CONSTRUCTION planning; PRIVATE sector; BIONTECH SE
- Publication
Pharma + Food, 2023, p8
- ISSN
1434-8942
- Publication type
Article